{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-329003","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2021-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.112894+00:00","generated_at":"2026-06-28T08:22:35.191234+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acumen Q3 loss $3.9M, cash $229.9M; ACU193 Phase 1 trial enrolling","bullets":["Net loss $3.9M (Q3), $92.3M (9M) including $80.3M non-cash fair-value charges from preferred stock and warrant liabilities.","Cash and marketable securities $229.9M at Sep 30, 2021 (vs. $43.8M at Dec 2020); IPO net proceeds $168.6M in July 2021.","R&D expenses $1.8M (Q3), G&A $2.1M; loss from operations $3.9M.","INTERCEPT-AD Phase 1 trial of ACU193 (anti-AβO antibody) dosed first patient; sentinel safety review passed.","Topline data expected by end of 2022; COVID-19 Delta variant delayed site activation but recruitment ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-329003","json":"https://secwatch.observer/filing/0001193125-21-329003.json","markdown":"https://secwatch.observer/filing/0001193125-21-329003.md","text":"https://secwatch.observer/filing/0001193125-21-329003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000119312521329003/0001193125-21-329003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000119312521329003/d255444d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T08:22:35.191234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}